Results 161 to 170 of about 389 (236)

[Therapy of urologic neoplasms by interferons].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1986
openaire   +1 more source

Comparison of staff workload between percutaneous nephrolithotomy with and without intraoperative cone‐beam CT: an 18‐month postoperative analysis

BJU International, Volume 138, Issue 1, Page 116-124, July 2026.
Objectives To assess whether hybrid cone‐beam computed tomography (CBCT)‐percutaneous nephrolithotomy (PCNL) reduces overall staff demands compared to standard PCNL. Patients and Methods We performed a retrospective study of a randomised controlled trial conducted in a tertiary Dutch urolithiasis centre.
Chris A. Suijker, Rosanne van Ee, Antoinette D. I. van Asselt, Inge M. van Oort, Riemer A. Kingma, Stijn Roemeling   +5 more
wiley   +1 more source

Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancer

BJU International, Volume 138, Issue 1, Page 125-132, July 2026.
Objective To describe the recurrence and progression trends of non‐muscle‐invasive bladder cancer (NMIBC) during a 14‐year period in Denmark between 2009 and 2022. Furthermore, to evaluate the risk of late recurrence with or without progression in patients who initially experience a 5‐year recurrence‐free interval (RFI).
Peter B. Hjort, Jørgen B. Jensen, Andreas Ernst   +2 more
wiley   +1 more source

Iatrogenic ureteric injuries after abdominal surgery: a systematic review and meta‐regression from the European Association of Urology Endourology Section

BJU International, Volume 138, Issue 1, Page 45-56, July 2026.
Objective To systematically evaluate management strategies and associated outcomes of iatrogenic ureteric injuries, focusing on clinical success, renal unit loss, and the need for subsequent endoscopic or reconstructive procedures. Patients and Methods A pre‐registered protocol (CRD420251184018) guided a comprehensive search of PubMed and EMBASE ...
Pietro Scilipoti, Nicola Nannola, Federico Zorzi, Carlos Gonzalez Gonzalez, Marie Chicaud, Luigi Candela, Stefano Moretto, Carlotta Nedbal, Tzevat Tefik, Luca Villa, Eugenio Ventimiglia, Andrea Salonia, Alberto Briganti, Francesco Montorsi, Bhaskar K. Somani, Steeve Doizi, Olivier Traxer, Frederic Panthier   +17 more
wiley   +1 more source

A Delphi consensus for implementing genomic testing in unresectable or metastatic urothelial cancer

BJU International, Volume 138, Issue 1, Page 144-155, July 2026.
Objectives To establish a UK consensus vision of a standardised genomic testing pathway in unresectable/metastatic urothelial cancer (mUC) with clear roles and responsibilities for multidisciplinary team (MDT) members and molecular pathology laboratory teams, and to agree how the pathway must evolve to accommodate emerging innovations.
Syed A. Hussain, Amarnath Challapalli, Simran Gill, Michael Hubank, Hannah Markham, Philippe Tanière, Simon Wyatt, Robert Jones   +7 more
wiley   +1 more source

Nodal maximum standardised uptake value improves PSMA‐PET/CT‐based nodal staging in intermediate‐ and high‐risk prostate cancer

BJU International, Volume 138, Issue 1, Page 133-143, July 2026.
Objectives To evaluate whether nodal maximum standardised uptake value (SUVmax) improves the positive predictive value (PPV) of prostate‐specific membrane antigen (PSMA) positron emission tomography (PET)/computerised tomography (CT) for detecting lymph node invasion (LNI) in prostate cancer (PCa), and to develop clinical decision tools to guide ...
Alexandra S. Bruins Slot, Vera Sweere, Joris G. Heetman, Rick Hermsen, Lieke Wever, Jules Lavalaye, Maarten Vinken, Clinton D. Bahler, Mark Tann, Claudia Kesch, Tugce Telli, Wolfgang P. Fendler, Peter Ka‐Fung Chiu, Kwan Kit Wu, Fabio Zattoni, Laura Evangelista, Francesco Ceci, Marcin Miszczyk, Pawel Rajwa, Akihiro Matsukawa, Tamás Fazekas, Francesco Barletta, Alberto Briganti, Francesco Montorsi, Giorgio Gandaglia, Jean‐Paul A. Van Basten, Harm H. E. Van Melick, Roderick C. N. Van den Bergh, Giancarlo Marra, Timo F. W. Soeterik, Matthijs J. V. Scheltema, on behalf of the European Association of Urology‐Young Academic Urologists (EAU‐YAU) Prostate Cancer Working Group   +31 more
wiley   +1 more source

[Brazilian Society of Urology. Guidelines on penile neoplasm].

International braz j urol : official journal of the Brazilian Society of Urology, 2014
Lucio Flávio, Gonzaga-Silva, Stênio de Cássio, Zequi, Agnaldo César, Nardi, Gustavo Franco, Carvalhal, José Carlos, de Almeida, Antonio Carlos Lima, Pompeo, Renato, Scaletscky, André G, Cavalcanti, Antonio Augusto, Ornellas, Carlos Eduardo Corradi, Fonseca, Ubirajara, Ferreira, Marcos Tobias, Machado, Eloísio Alexandro, da Silva, Misael Wanderley, dos Santos Júnior, Alvaro Sadek, Sarkis, Francisco Flávio Horta, Bretas, Rogério Matos, Araújo, Mário Ronalsa, Brandão Filho, Felipe, Dubourq   +18 more
openaire   +1 more source

Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy

BJU International, Volume 138, Issue 1, Page 156-163, July 2026.
Objectives To quantify the relative contribution of radiologists and urologists to variability in clinically significant prostate cancer (CSPC) detection across multiparametric magnetic resonance imaging (mpMRI)‐guided prostate fusion biopsies and to determine whether this differed across Prostate Imaging‐Reporting And Data System (PI‐RADS) categories.
Daniel Triner, Kevin B. Ginsburg, Ana Moser, Corinne Labardee, Howard Korman, Jason Domina, Michael L. Cher, James Peabody, Alice Semerjian, Andrei Purysko, Arvin K. George, Tudor Borza, Andrew E. Krumm, for the Michigan Urological Surgery Improvement Collaborative (MUSIC)   +13 more
wiley   +1 more source

The first United States prospective trial using the Hugo™ robot‐assisted surgery system

BJU International, Volume 138, Issue 1, Page 85-91, July 2026.
Objective To describe the safety and effectiveness of the Hugo™ robot‐assisted surgery (RAS) system (Medtronic, Minneapolis, MN, USA) when used for three urological procedures. Patients and Methods The Expand URO (ClinicalTrials.gov identifier: NCT05696444) was the first investigational study for the Hugo RAS system based in the United States. It was a
Michael R. Abern, Peter Wiklund, Alvin C. Goh, Jihad H. Kaouk, Simone Crivellaro, Clayton S. Lau, Ali A. Zhumkhawala, Rogerio Huang, Reza Mehrazin, John P. Sfakianos, Ikenna Madueke, Brant A. Inman, Casey Blaser, Michele Masters, James R. Porter   +14 more
wiley   +1 more source

Aligning bladder cancer research with patient needs: an update on research priorities

BJU International, Volume 138, Issue 1, Page 70-71, July 2026.
Nada Humayun‐Zakaria, Benjamin J. Tura, Mieke van Hemelrijck, Richard T. Bryan   +3 more
wiley   +1 more source